2025 International Congress Archives - Page 56 of 181

Disease Characteristics of the First 100 Participants in the CurePSP Genetics Program Cohort

C. Obasi, V. Zhao, C. Martinez, S. Scholz, H. Morris, N. Mcfarland, M. Nance, J. Wang, N. Mencacci, B. Cuoto, T. Foroud, J. Verbrugge, A. Miller, L. Heathers, L. Honig, A. Lang, F. Rodriguez-Porcel, P. Moretti, M. Mesaros, J. Brummet, K. Diaz, A. Wills (Boston, USA)
Disease Modifying Potential of a Novel ROCK Inhibitor in Rodent Models of Synucleinopathy

M. Kubik, J. Mackeigan, A. Stoll, J. Patterson, J. Lipton, K. Steece-Collier, A. Cole-Strauss, C. Kemp, J. Howe, K. Miller, F. Manfredsson, S. Celano, K. Luk, C. Sortwell (Grand Rapids, USA)
Disease Monitoring through the PKAN Disease Rating Scale (PKAN-DRS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN)

A. Salazar-Villacorta, R. Spaull, M. Correa-Vela, A. Cazurro, J. Ferrero Turión, A. Soo, M. González, A. Macaya, B. Pérez-Dueñas, M. Kurian (London, United Kingdom)
Disparities in Parkinson’s Disease Care Access in Hawaii

K. Thai, E. Krening, R. Shuman, M. Faouzi, G. Ross, L. Terpak, F. Gao, M. Bruno (Honolulu, USA)
Disrupted NOVA2-Mediated Splicing by (TTTCA) Repeat Expansion: Unveiling Aberrant Synaptic Gene Regulation in FCMTE1

YL. Chen, F. Zhang, ZD. Cen, W. Luo (Hangzhou, China)
Distinct Peripheral Immune Profiles of Parkinson’s Disease and Multiple System Atrophy

S. Jo, I. Jang, J. Lee, M. Choi, E. Lee, SJ. Chung (Seoul, Republic of Korea)
Distinct roles of PARK2, PINK1, and LRRK2 in neuroinflammation: resistance and susceptibility in immune-mediated mouse models

D. Cossu, H. Okada, S. Noda, Y. Tomizawa, S. Ueno, L. Sechi, T. Hatano, N. Hattori (Tokyo, Japan)
Distinguishing DBS and Non-DBS Parkinson’s Patients Using Recurrence Plots and Vision Transformers

V. Skaramagkas, G. Karamanis, I. Boura, C. Chatzaki, I. Kyprakis, D. Fotiadis, C. Spanaki, Z. Kefalopoulou, M. Tsiknakis (Estavromenos, Heraklion, Greece)
Distinguishing Functional and Essential Tremor from Tremor in Parkinson’s Disease using an objective comprehensive Motor Symptom Assessment Device

D. Bramwell, C. Papasavvas, M. Walter, A. Dimelow, A. Deutschländer, R. Zietsma (Newcastle upon Tyne, United Kingdom)
Distribution of Chronotypes in Parkinson’s Disease and its association with Pathological Sleepiness

A. Sarwar (Houston, USA)